Mutant p53 Gain-of-Function in Cancer

被引:594
作者
Oren, Moshe [1 ]
Rotter, Varda [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
关键词
LI-FRAUMENI-SYNDROME; P53-INDEPENDENT APOPTOTIC PATHWAYS; LUNG-SPECIFIC EXPRESSION; TUMOR-SUPPRESSOR P53; GENE-EXPRESSION; TGF-BETA; FUNCTION PHENOTYPE; WILD-TYPE; FUNCTION MUTATIONS; TRANSGENIC MICE;
D O I
10.1101/cshperspect.a001107
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In its wild-type form, p53 is a major tumor suppressor whose function is critical for protection against cancer. Many human tumors carry missense mutations in the TP53 gene, encoding p53. Typically, the affected tumor cells accumulate excessive amounts of the mutant p53 protein. Various lines of evidence indicate that, in addition to abrogating the tumor suppressor functions of wild-type p53, the common types of cancer-associated p53 mutations also endow the mutant protein with new activities that can contribute actively to various stages of tumor progression and to increased resistance to anticancer treatments. Collectively, these activities are referred to as mutant p53 gain-of-function. This article addresses the biological manifestations of mutant p53 gain-of-function, the underlying molecular mechanisms, and their possible clinical implications.
引用
收藏
页数:15
相关论文
共 105 条
[11]   An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations [J].
Caulin, Carlos ;
Nguyen, Thao ;
Lang, Gene A. ;
Goepfert, Thea M. ;
Brinkley, Bill R. ;
Cai, Wei-Wen ;
Lozano, Guillermina ;
Roop, Dennis R. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (07) :1893-1901
[12]   MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53 [J].
CHIN, KV ;
UEDA, K ;
PASTAN, I ;
GOTTESMAN, MM .
SCIENCE, 1992, 255 (5043) :459-462
[13]   Links between tumor suppressors:: p53 is required for TGF-β gene responses by cooperating with Smads [J].
Cordenonsi, M ;
Dupont, S ;
Maretto, S ;
Insinga, A ;
Imbriano, C ;
Piccolo, S .
CELL, 2003, 113 (03) :301-314
[14]  
Deb D, 2002, ONCOGENE, V21, P176, DOI 10.1038/sj/onc/1205035
[15]   MODULATION OF CELLULAR AND VIRAL PROMOTERS BY MUTANT HUMAN P53-PROTEINS FOUND IN TUMOR-CELLS [J].
DEB, S ;
JACKSON, CT ;
SUBLER, MA ;
MARTIN, DW .
JOURNAL OF VIROLOGY, 1992, 66 (10) :6164-6170
[16]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[17]   Differentiation plasticity regulated by TGF-β family proteins in development and disease [J].
Derynck, Rik ;
Akhurst, Rosemary J. .
NATURE CELL BIOLOGY, 2007, 9 (09) :1000-1004
[18]   The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs [J].
Di Agostino, Silvia ;
Cortese, Giancarlo ;
Monti, Olimpia ;
Dell'Orso, Stefania ;
Sacchi, Ada ;
Eisenstein, Miriam ;
Citro, Gennaro ;
Strano, Sabrina ;
Blandino, Giovanni .
CELL CYCLE, 2008, 7 (21) :3440-3447
[19]   Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation [J].
Di Agostino, Silvia ;
Strano, Sabrina ;
Emiliozzi, Velia ;
Zerbini, Valentina ;
Mottolese, Farcella ;
Sacchi, Ada ;
Blandino, Giovanni ;
Piaggio, Giulia .
CANCER CELL, 2006, 10 (03) :191-202
[20]   GAIN OF FUNCTION MUTATIONS IN P53 [J].
DITTMER, D ;
PATI, S ;
ZAMBETTI, G ;
CHU, S ;
TERESKY, AK ;
MOORE, M ;
FINLAY, C ;
LEVINE, AJ .
NATURE GENETICS, 1993, 4 (01) :42-46